Genomic characterization of SARS-CoV-2 from Uganda using MinION nanopore sequencing

Abstract SARS-CoV-2 undergoes frequent mutations, affecting COVID-19 diagnostics, transmission and vaccine efficacy. Here, we describe the genetic diversity of 49 SARS-CoV-2 samples from Uganda, collected during the COVID-19 waves of 2020/2021. Overall, the samples were similar to previously reporte...

Full description

Bibliographic Details
Main Authors: Praiscillia Kia, Eric Katagirya, Fredrick Elishama Kakembo, Doreen Ato Adera, Moses Luutu Nsubuga, Fahim Yiga, Sharley Melissa Aloyo, Brendah Ronah Aujat, Denis Foe Anguyo, Fred Ashaba Katabazi, Edgar Kigozi, Moses L. Joloba, David Patrick Kateete
Format: Article
Language:English
Published: Nature Portfolio 2023-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-47379-z
_version_ 1797452881008263168
author Praiscillia Kia
Eric Katagirya
Fredrick Elishama Kakembo
Doreen Ato Adera
Moses Luutu Nsubuga
Fahim Yiga
Sharley Melissa Aloyo
Brendah Ronah Aujat
Denis Foe Anguyo
Fred Ashaba Katabazi
Edgar Kigozi
Moses L. Joloba
David Patrick Kateete
author_facet Praiscillia Kia
Eric Katagirya
Fredrick Elishama Kakembo
Doreen Ato Adera
Moses Luutu Nsubuga
Fahim Yiga
Sharley Melissa Aloyo
Brendah Ronah Aujat
Denis Foe Anguyo
Fred Ashaba Katabazi
Edgar Kigozi
Moses L. Joloba
David Patrick Kateete
author_sort Praiscillia Kia
collection DOAJ
description Abstract SARS-CoV-2 undergoes frequent mutations, affecting COVID-19 diagnostics, transmission and vaccine efficacy. Here, we describe the genetic diversity of 49 SARS-CoV-2 samples from Uganda, collected during the COVID-19 waves of 2020/2021. Overall, the samples were similar to previously reported SARS-CoV-2 from Uganda and the Democratic Republic of Congo (DRC). The main lineages were AY.46 and A.23, which are considered to be Delta SARS-CoV-2 variants. Further, a total of 268 unique single nucleotide variants and 1456 mutations were found, with more than seventy percent mutations in the ORF1ab and S genes. The most common mutations were 2042C>G (83.4%), 14143C>T (79.5%), 245T>C (65%), and 1129G>T (51%), which occurred in the S, ORF1ab, ORF7a and N genes, respectively. As well, 28 structural variants—21 insertions and 7 deletions, occurred in 16 samples. Our findings point to the possibility that most SARS-CoV-2 infections in Uganda at the time arose from local spread and were not newly imported. Moreover, the relatedness of variants from Uganda and the DRC reflects high human mobility and interaction between the two countries, which is peculiar to this region of the world.
first_indexed 2024-03-09T15:15:05Z
format Article
id doaj.art-db61a8d437e44d69819bda577891ca8d
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-09T15:15:05Z
publishDate 2023-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-db61a8d437e44d69819bda577891ca8d2023-11-26T13:09:53ZengNature PortfolioScientific Reports2045-23222023-11-011311810.1038/s41598-023-47379-zGenomic characterization of SARS-CoV-2 from Uganda using MinION nanopore sequencingPraiscillia Kia0Eric Katagirya1Fredrick Elishama Kakembo2Doreen Ato Adera3Moses Luutu Nsubuga4Fahim Yiga5Sharley Melissa Aloyo6Brendah Ronah Aujat7Denis Foe Anguyo8Fred Ashaba Katabazi9Edgar Kigozi10Moses L. Joloba11David Patrick Kateete12Department of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere UniversityDepartment of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere UniversityThe African Centers of Excellence in Bioinformatics and Date Intensive Sciences, Infectious Disease Institute, College of Health Sciences, Makerere UniversityMultifunctional Research Laboratories, Gulu UniversityDepartment of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere UniversityDepartment of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere UniversityDepartment of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere UniversityDepartment of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere UniversityDepartment of Biology, Muni UniversityDepartment of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere UniversityDepartment of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere UniversityDepartment of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere UniversityDepartment of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere UniversityAbstract SARS-CoV-2 undergoes frequent mutations, affecting COVID-19 diagnostics, transmission and vaccine efficacy. Here, we describe the genetic diversity of 49 SARS-CoV-2 samples from Uganda, collected during the COVID-19 waves of 2020/2021. Overall, the samples were similar to previously reported SARS-CoV-2 from Uganda and the Democratic Republic of Congo (DRC). The main lineages were AY.46 and A.23, which are considered to be Delta SARS-CoV-2 variants. Further, a total of 268 unique single nucleotide variants and 1456 mutations were found, with more than seventy percent mutations in the ORF1ab and S genes. The most common mutations were 2042C>G (83.4%), 14143C>T (79.5%), 245T>C (65%), and 1129G>T (51%), which occurred in the S, ORF1ab, ORF7a and N genes, respectively. As well, 28 structural variants—21 insertions and 7 deletions, occurred in 16 samples. Our findings point to the possibility that most SARS-CoV-2 infections in Uganda at the time arose from local spread and were not newly imported. Moreover, the relatedness of variants from Uganda and the DRC reflects high human mobility and interaction between the two countries, which is peculiar to this region of the world.https://doi.org/10.1038/s41598-023-47379-z
spellingShingle Praiscillia Kia
Eric Katagirya
Fredrick Elishama Kakembo
Doreen Ato Adera
Moses Luutu Nsubuga
Fahim Yiga
Sharley Melissa Aloyo
Brendah Ronah Aujat
Denis Foe Anguyo
Fred Ashaba Katabazi
Edgar Kigozi
Moses L. Joloba
David Patrick Kateete
Genomic characterization of SARS-CoV-2 from Uganda using MinION nanopore sequencing
Scientific Reports
title Genomic characterization of SARS-CoV-2 from Uganda using MinION nanopore sequencing
title_full Genomic characterization of SARS-CoV-2 from Uganda using MinION nanopore sequencing
title_fullStr Genomic characterization of SARS-CoV-2 from Uganda using MinION nanopore sequencing
title_full_unstemmed Genomic characterization of SARS-CoV-2 from Uganda using MinION nanopore sequencing
title_short Genomic characterization of SARS-CoV-2 from Uganda using MinION nanopore sequencing
title_sort genomic characterization of sars cov 2 from uganda using minion nanopore sequencing
url https://doi.org/10.1038/s41598-023-47379-z
work_keys_str_mv AT praiscilliakia genomiccharacterizationofsarscov2fromugandausingminionnanoporesequencing
AT erickatagirya genomiccharacterizationofsarscov2fromugandausingminionnanoporesequencing
AT fredrickelishamakakembo genomiccharacterizationofsarscov2fromugandausingminionnanoporesequencing
AT doreenatoadera genomiccharacterizationofsarscov2fromugandausingminionnanoporesequencing
AT mosesluutunsubuga genomiccharacterizationofsarscov2fromugandausingminionnanoporesequencing
AT fahimyiga genomiccharacterizationofsarscov2fromugandausingminionnanoporesequencing
AT sharleymelissaaloyo genomiccharacterizationofsarscov2fromugandausingminionnanoporesequencing
AT brendahronahaujat genomiccharacterizationofsarscov2fromugandausingminionnanoporesequencing
AT denisfoeanguyo genomiccharacterizationofsarscov2fromugandausingminionnanoporesequencing
AT fredashabakatabazi genomiccharacterizationofsarscov2fromugandausingminionnanoporesequencing
AT edgarkigozi genomiccharacterizationofsarscov2fromugandausingminionnanoporesequencing
AT mosesljoloba genomiccharacterizationofsarscov2fromugandausingminionnanoporesequencing
AT davidpatrickkateete genomiccharacterizationofsarscov2fromugandausingminionnanoporesequencing